Drug developer dips on failed psoriasis trial
January 02, 2020 at 17:28 PM EST
The company's stock had reached a 52-week high on New Year's Eve day.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|